Oak Thistle LLC Acquires New Stake in Sotera Health (NASDAQ:SHC)

Oak Thistle LLC acquired a new position in shares of Sotera Health (NASDAQ:SHC) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 16,247 shares of the company’s stock, valued at approximately $222,000.

Several other institutional investors have also recently added to or reduced their stakes in SHC. Darsana Capital Partners LP boosted its holdings in shares of Sotera Health by 716.9% during the third quarter. Darsana Capital Partners LP now owns 20,010,000 shares of the company’s stock worth $334,167,000 after purchasing an additional 17,560,636 shares during the last quarter. Sessa Capital IM L.P. lifted its position in Sotera Health by 46.5% during the third quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company’s stock worth $105,220,000 after buying an additional 2,000,000 shares during the period. State Street Corp boosted its stake in Sotera Health by 18.5% in the 3rd quarter. State Street Corp now owns 4,126,806 shares of the company’s stock worth $68,918,000 after buying an additional 644,236 shares during the last quarter. AQR Capital Management LLC grew its holdings in Sotera Health by 3,198.2% in the 2nd quarter. AQR Capital Management LLC now owns 511,580 shares of the company’s stock valued at $6,072,000 after buying an additional 496,069 shares during the period. Finally, Geode Capital Management LLC increased its stake in shares of Sotera Health by 19.4% during the 3rd quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock valued at $46,026,000 after acquiring an additional 447,186 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. Citigroup raised their target price on shares of Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Royal Bank of Canada reissued an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st. Finally, The Goldman Sachs Group began coverage on Sotera Health in a report on Friday, December 6th. They set a “neutral” rating and a $14.00 price objective for the company. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $16.08.

Sotera Health Stock Performance

NASDAQ:SHC opened at $12.98 on Friday. The firm’s fifty day simple moving average is $13.49 and its 200 day simple moving average is $14.41. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.44. The firm has a market capitalization of $3.68 billion, a price-to-earnings ratio of 51.92 and a beta of 1.92.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). The company had revenue of $285.47 million for the quarter, compared to analyst estimates of $278.64 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The company’s revenue for the quarter was up 8.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.18 EPS. As a group, equities research analysts expect that Sotera Health will post 0.61 earnings per share for the current fiscal year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.